Delivery Order SPE2DB22D1200-SPE2DB25FN4PF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,833.96 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count) on August 13, 2025. This is a firm fixed price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 14, 2025. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Trokendi XR 100 mg capsules (30-count). The contract ceiling value is $1,304.52, with an ultimate completion date of May 13, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,689.54 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count) on July 24, 2025, with completion expected by July 25, 2025. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a $29,860.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units). The award was made without a set-aside designation through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location. This delivery order represents a child contract action under the...
- The Defense Logistics Agency awarded a $4,622.34 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units). This non-set-aside contract was competitively awarded and is scheduled for completion by August 21, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,689.54 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count). This firm fixed-price, competitively awarded contract with no set-aside designation was executed on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Trokendi XR 25 mg capsules (30-count) valued at $1,476.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by May 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Trokendi XR 50 mg capsules (30-count) with a ceiling value of $2,995.93. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 8, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion...
- The Defense Logistics Agency awarded a delivery order valued at $11,571.94 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 200 mg capsules (30-count units) under a firm fixed price contract. The delivery order, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a non-set-aside award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $1,309.32 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Trokendi XR 25 mg capsules (30-count package). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB25FN4PFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,207.55 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count) under a firm fixed-price arrangement. The contract, which was competitively awarded without set-aside designation, is scheduled for completion by September 24, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999 through December 2026. AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors and healthcare solutions providers, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company's DLA prime vendor contract enables it to supply a broad portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers globally. The Trokendi XR delivery under this order supports ongoing federal medical supply requirements for this neurological treatment medication.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 9/23/25 |